Tata India Pharma & Healthcare Fund vs UTI Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1309 Cr | ₹1119 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 28 Dec 2015 | 30 Jul 2005 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | Nifty Pharma TRI | BSE Healthcare |
Turn Over | 26.49% | 28% |
Expense Ratio | 2.14 | 2.22 |
Manager | Meeta Shetty | Kamal Gada |
ISIN Code | INF277K016A9 | INF789F01695 |
Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Month | -0.3% | 0.49% |
6 Month | 13.11% | 15.93% |
1 Year | -1.76% | 2.59% |
3 Year | 24.36% | 26.6% |
5 Year | 18.23% | 18.27% |
SIP Return Analysis
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
6 Month | 3.9% | 5.59% |
1 Year | 9.27% | 13.89% |
3 Year | 22.51% | 26.3% |
5 Year | 19.09% | 20.61% |
Rolling Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Year | 10.55% | 12.22% |
3 Year | 18.34% | 16.31% |
5 Year | 15.18% | 14.54% |
Risk Management
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Standard Deviation | 15.94% | 15.66% |
Sharp | 0.99% | 1.09% |
Beta | 0.98% | 0.95% |
Alpha | -0.12% | 1.61% |
Fund Managers
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Name | Meeta Shetty | Kamal Gada |
Total AUM | ₹17847 Cr | ₹870 Cr |
Funds Managed | 5 | 1 |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 8.59 | 5.33 |
Large Cap | 27.92 | 23.12 |
Mid Cap | 32.96 | 31.48 |
Small Cap | 30.52 | 40.07 |
Sector Allocation
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 6.22 | 2.34 |
Basic Materials | 0.46 | 1.03 |
Healthcare | 91.69 | 96.62 |
Financial Services | 1.63 | - |
Top Comparisons
Sundaram Financial Services Opportunities Fund Regular Plan - Growth
3Y Returns16.7%
Quant BFSI Fund Regular - Growth
3Y Returns0%
ICICI Prudential Thematic Advantage Fund (FOF) - Growth
3Y Returns19.49%
Mirae Asset Nifty India Manufacturing ETF FOF - Regular Plan - Growth
3Y Returns21.55%
Aditya Birla Sun Life Government Securities Fund - Growth - Regular Plan
3Y Returns6.6%
Aditya Birla Sun Life Government Securities Fund - Growth - Regular Plan
3Y Returns6.6%
Mirae Asset Short Duration Fund- Regular Plan -Growth
3Y Returns7%
Axis Short Duration Fund - Regular Plan - Growth Option
3Y Returns7.51%